Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: April 5, 2006
Last updated: June 25, 2013
Last verified: April 2008